iShares US Pharmaceuticals ETF
IHE
IHE
101 hedge funds and large institutions have $87.9M invested in iShares US Pharmaceuticals ETF in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
39% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 31
Holders
101
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.34M | |
| 2 | +$2.9M | |
| 3 | +$1.65M | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$449K |
| 5 |
LPL Financial
San Diego,
California
|
+$321K |
Top Sellers
| 1 | -$6.21M | |
| 2 | -$2.56M | |
| 3 | -$1.01M | |
| 4 |
PAG
Pinnacle Advisory Group
Columbia,
Maryland
|
-$713K |
| 5 |
Morgan Stanley
New York
|
-$350K |